Bulletin
Investor Alert

New York Markets Open in:

Danaher Corp.

NYS: DHR

GO
/marketstate/country/us

Before the Bell

 --Quotes are delayed by 20 min

Aug 3, 2020, 4:41 a.m.

DHR
/zigman2/quotes/210555154/composite

$

203.80

Change

0.00 0.00%

Volume

Volume 300

Quotes are delayed by 20 min

/zigman2/quotes/210555154/composite

Previous close

$ 203.80

$ 203.80

Change

+1.66 +0.82%

Day low

Day high

$200.87

$203.95

Open

52 week low

52 week high

$119.60

$204.13

Open

Company Description

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offer...

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Valuation

P/E Current

59.37

P/E Ratio (with extraordinary items)

43.39

P/E Ratio (without extraordinary items)

44.71

Price to Sales Ratio

6.22

Price to Book Ratio

3.72

Price to Cash Flow Ratio

28.18

Enterprise Value to EBITDA

25.22

Enterprise Value to Sales

6.45

Total Debt to Enterprise Value

0.19

Efficiency

Revenue/Employee

298,518.00

Income Per Employee

40,538.00

Receivables Turnover

5.30

Total Asset Turnover

0.33

Liquidity

Current Ratio

5.19

Quick Ratio

4.86

Cash Ratio

4.04

Profitability

Gross Margin

55.74

Operating Margin

18.77

Pretax Margin

18.45

Net Margin

13.58

Return on Assets

4.43

Return on Equity

8.32

Return on Total Capital

7.41

Return on Invested Capital

5.39

Capital Structure

Total Debt to Total Equity

78.57

Total Debt to Total Capital

42.67

Total Debt to Total Assets

36.28

Long-Term Debt to Equity

77.28

Long-Term Debt to Total Capital

41.96

Officers and Executives

Name Age Officer Since Title
Mr. Steven M. Rales 67 1969 Chairman
Mr. Thomas Patrick Joyce 58 1989 Executive Vice President
Mr. Matthew R. McGrew 47 - Chief Financial Officer & Executive Vice President
Mr. Jeffrey S. Kappler 40 2007 Factory Manager
Ms. Mischa M. Reis 47 2012 VP-Business Development & Strategy

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
07/29/2020 Matthew R. McGrew
EVP & Chief Financial Officer
7,457   Disposition at $203.42 per share. 1,516,902
07/28/2020 Walter G. Lohr
Director
57,000   Disposition at $198.56 per share. 11,317,920
07/28/2020 William H. King
SVP, Strategic Development
18,750   Disposition at $199.05 per share. 3,732,187
07/28/2020 William H. King
SVP, Strategic Development
8,232   Disposition at $199.18 per share. 1,639,649
07/28/2020 William H. King
SVP, Strategic Development
18,750   Derivative/Non-derivative trans. at $57.9 per share. 1,085,625
07/28/2020 William H. King
SVP, Strategic Development
8,232   Derivative/Non-derivative trans. at $46.13 per share. 379,742
07/27/2020 Daniel L. Comas
EVP
3,540   Disposition at $201.53 per share. 713,416
07/27/2020 Daniel L. Comas
EVP
4,460   Disposition at $200.34 per share. 893,516
07/27/2020 Joakim Weidemanis
Executive Vice President
19,834   Disposition at $196 per share. 3,887,464
07/27/2020 Linda Hefner Filler
Director
2,754   Disposition at $197 per share. 542,538
07/27/2020 Elias A. Zerhouni
Director
1,605   Derivative/Non-derivative trans. at $198.98 per share. 319,362
07/27/2020 Joakim Weidemanis
Executive Vice President
19,834   Derivative/Non-derivative trans. at $36.87 per share. 731,279
07/27/2020 Elias A. Zerhouni
Director
11,014   Derivative/Non-derivative trans. at $28.98 per share. 319,185
07/27/2020 Linda Hefner Filler
Director
8,260   Derivative/Non-derivative trans. at $28.98 per share. 239,374
07/27/2020 Linda Hefner Filler
Director
2,754   Derivative/Non-derivative trans. at $28.98 per share. 79,810
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
100   Disposition at $196.75 per share. 19,675
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
40,936   Disposition at $194.99 per share. 7,982,110
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
27,781   Disposition at $194 per share. 5,389,514
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
18,869   Disposition at $193.08 per share. 3,643,226
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
7,517   Disposition at $192.25 per share. 1,445,143
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
4,135   Disposition at $191.1 per share. 790,198
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
100   Disposition at $197.01 per share. 19,701
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
33,587   Disposition at $194.99 per share. 6,549,129
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
21,971   Disposition at $194.02 per share. 4,262,813
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
17,038   Disposition at $193.1 per share. 3,290,037
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
6,360   Disposition at $192.21 per share. 1,222,455
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
3,000   Disposition at $191.04 per share. 573,120
07/24/2020 Daniel L. Comas
EVP
3,054   Disposition at $195.27 per share. 596,354
07/24/2020 Daniel L. Comas
EVP
16,821   Disposition at $195.1 per share. 3,281,777
07/24/2020 Daniel L. Comas
EVP
18,085   Disposition at $194.4 per share. 3,515,724
07/24/2020 Daniel L. Comas
EVP
13,160   Disposition at $193.44 per share. 2,545,670
07/24/2020 Daniel L. Comas
EVP
8,312   Disposition at $192.47 per share. 1,599,810
07/24/2020 Daniel L. Comas
EVP
2,600   Disposition at $190.99 per share. 496,574
07/24/2020 Daniel L. Comas
EVP
9,505   Disposition at $195.07 per share. 1,854,140
07/24/2020 Daniel L. Comas
EVP
8,790   Disposition at $194.32 per share. 1,708,072
07/24/2020 Daniel L. Comas
EVP
6,890   Disposition at $193.36 per share. 1,332,250
07/24/2020 Daniel L. Comas
EVP
3,615   Disposition at $192.39 per share. 695,489
07/24/2020 Daniel L. Comas
EVP
1,200   Disposition at $190.99 per share. 229,188
07/24/2020 John T. Schwieters
Director
428   Disposition at $195.37 per share. 83,618
07/24/2020 John T. Schwieters
Director
2,538   Disposition at $194.79 per share. 494,377
07/24/2020 John T. Schwieters
Director
1,800   Disposition at $193.62 per share. 348,516
07/24/2020 John T. Schwieters
Director
1,000   Disposition at $192.52 per share. 192,520
07/24/2020 John T. Schwieters
Director
248   Disposition at $191.01 per share. 47,370
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
99,338   Derivative/Non-derivative trans. at $65.95 per share. 6,551,341
07/24/2020 Thomas Patrick Joyce
President and CEO; Director
82,056   Derivative/Non-derivative trans. at $65.83 per share. 5,401,746
07/24/2020 Daniel L. Comas
EVP
58,978   Derivative/Non-derivative trans. at $56.7 per share. 3,344,052
07/24/2020 Daniel L. Comas
EVP
30,000   Derivative/Non-derivative trans. at $65.83 per share. 1,974,900
07/24/2020 John T. Schwieters
Director
5,000   Derivative/Non-derivative trans. at $28.98 per share. 144,900
07/24/2020 John T. Schwieters
Director
6,014   Derivative/Non-derivative trans. at $28.98 per share. 174,285
05/29/2020 Mitchell P. Rales
Chairman of Exec. Committee; Director
15,167   Acquisition at $166.75 per share. 2,529,097
05/29/2020 Mitchell P. Rales
Chairman of Exec. Committee; Director
26,386   Acquisition at $165.74 per share. 4,373,215
05/29/2020 Mitchell P. Rales
Chairman of Exec. Committee; Director
38,019   Acquisition at $164.62 per share. 6,258,687
05/29/2020 Mitchell P. Rales
Chairman of Exec. Committee; Director
61,848   Acquisition at $163.79 per share. 10,130,083
05/28/2020 Walter G. Lohr
Director
11,014   Disposition at $165.61 per share. 1,824,028
05/28/2020 Rainer Blair
Executive Vice President
3,330   Disposition at $165.96 per share. 552,646
05/28/2020 Walter G. Lohr
Director
11,014   Derivative/Non-derivative trans. at $28.98 per share. 319,185
05/18/2020 Daniel L. Comas
EVP
18,259   Disposition at $165.68 per share. 3,025,151
05/15/2020 Walter G. Lohr
Director
575   Award at $0 per share. 0
05/15/2020 Alan G. Spoon
Director
575   Award at $0 per share. 0
05/15/2020 Joakim Weidemanis
Executive Vice President
18,515   Award at $0 per share. 0
05/15/2020 Elias A. Zerhouni
Director
575   Award at $0 per share. 0
05/15/2020 Linda Hefner Filler
Director
575   Award at $0 per share. 0
05/15/2020 John T. Schwieters
Director
575   Award at $0 per share. 0
05/15/2020 Teri L. List-Stoll
Director
575   Award at $0 per share. 0
05/15/2020 Raymond C. Stevens
Director
575   Award at $0 per share. 0
05/15/2020 Pardis C. Sabeti
Director
575   Award at $0 per share. 0
05/15/2020 Jessica L. Mega
Director
575   Award at $0 per share. 0
05/12/2020 Mitchell P. Rales
Chairman of Exec. Committee; Director
613   Acquisition at $163 per share. 99,919
05/12/2020 Mitchell P. Rales
Chairman of Exec. Committee; Director
613   Acquisition at $163 per share. 99,919
05/08/2020 Angela S. Lalor
SVP, Human Resources
8,031   Disposition at $163.03 per share. 1,309,293
05/08/2020 Brian W. Ellis
SVP, GC & CCO
2,870   Disposition at $163.4 per share. 468,958
05/08/2020 Daniel A. Raskas
SVP-Corporate Development
29,011   Disposition at $164.12 per share. 4,761,285
05/08/2020 Daniel A. Raskas
SVP-Corporate Development
8,071   Disposition at $164 per share. 1,323,644
05/08/2020 Robert S. Lutz
SVP-Chief Accounting Officer
28,389   Disposition at $161.67 per share. 4,589,649
05/08/2020 Robert S. Lutz
SVP-Chief Accounting Officer
5,503   Disposition at $161.72 per share. 889,945
05/08/2020 Daniel A. Raskas
SVP-Corporate Development
29,011   Derivative/Non-derivative trans. at $37.51 per share. 1,088,202
05/08/2020 Robert S. Lutz
SVP-Chief Accounting Officer
28,389   Derivative/Non-derivative trans. at $40.45 per share. 1,148,335
/news/latest/company/us/dhr

MarketWatch News on DHR

  1. GE Competitor Siemens Healthineers Makes Blockbuster Acquisition

    10:53 a.m. Aug. 2, 2020

    - Barron's Online

  2. GE Reports Earnings Tomorrow. Here’s What to Expect.

    10:41 a.m. July 28, 2020

    - Barron's Online

  3. Danaher stock price target raised to $233 from $176 at UBS

    9:37 a.m. July 27, 2020

    - Tomi Kilgore

  4. Tesla, AT&T, Microsoft, Intel, and Other Stocks to Watch This Week

    3:00 p.m. July 19, 2020

    - Barron's Online

  5. The Marathon Finds a Way

    9:41 a.m. July 22, 2020

    - Barron's Online

  6. Here Are a Few Sectors and Three Dozen Stocks for a Blue Wave

    1:30 p.m. July 7, 2020

    - Barron's Online

  7. GE Stock Is Down Because When It Rains It Pours

    1:20 p.m. June 11, 2020

    - Barron's Online

  8. How the Fed Saved a Pandemic-Rattled Stock Market

    11:18 a.m. May 22, 2020

    - Barron's Online

  9. Health-Care Stocks Popular With ESG Funds Outperform

    9:15 a.m. May 16, 2020

    - Barron's Online

  10. GE Stock Dropped Again. But Here’s What Is Going Right.

    5:03 p.m. May 14, 2020

    - Barron's Online

  11. Danaher launches offerings of $2.5 bln in common, convertible stock

    8:44 a.m. May 7, 2020

    - Tomi Kilgore

  12. GE Stock Nears Lowest Point in Years as Pandemic Hits Home

    12:30 p.m. April 29, 2020

    - Barron's Online

  13. Loading more headlines...
/news/nonmarketwatch/company/us/dhr

Other News on DHR

  1. Thermo Fisher Long Case: Trajectory Is Clear, Buy On Value

    3:50 p.m. July 31, 2020

    - Seeking Alpha

  2. Dover Proving That It Has Changed For The Better

    11:38 a.m. July 31, 2020

    - Seeking Alpha

  3. Ugly Earnings Results Aren’t the Real Problem for General Electric

    10:17 a.m. July 30, 2020

    - InvestorPlace.com

  4. The EVP of Danaher is Exercising Options

    8:00 a.m. July 29, 2020

    - SmarterAnalyst

  5. The President & CEO of Danaher is Exercising Options

    8:00 a.m. July 29, 2020

    - SmarterAnalyst

  6. Systemic Issues Will Continue to Jolt General Electric

    2:34 p.m. July 27, 2020

    - InvestorPlace.com

  7. Dividend Challenger Highlights: Week Of July 26

    3:24 p.m. July 25, 2020

    - Seeking Alpha

  8. Weitz Investment Management Q2 2020 Commentary

    12:15 p.m. July 23, 2020

    - Seeking Alpha

  9. FDA clears Beckman automated blood bank analyzer

    8:46 a.m. July 23, 2020

    - Seeking Alpha

  10. Danaher (DHR) Gets a Buy Rating from Needham

    8:05 a.m. July 23, 2020

    - SmarterAnalyst

  11. 10-Q: DANAHER CORP /DE/

    6:04 a.m. July 23, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  12. Danaher Corporation Q2 2020 Earnings Preview

    1:52 p.m. July 22, 2020

    - Seeking Alpha

  13. Notable earnings before Thursday's open

    1:05 p.m. July 22, 2020

    - Seeking Alpha

  14. Halma - Pay Up To Sleep Well At Night

    11:48 a.m. July 22, 2020

    - Seeking Alpha

  15. Don’t Miss Out on General Electric Stock’s 30% Upside

    10:24 a.m. July 22, 2020

    - InvestorPlace.com

  16. Loading more headlines...

At a Glance

Danaher Corp.

2200 Pennsylvania Avenue NW

Suite 800 West

Washington, District of Columbia 20037-1701

Phone

1 2028280850

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

$17.91B

Net Income

$2.43B

Employees

60,000

/news/pressrelease/company/us/dhr

Press Releases on DHR

  1. Danaher Reports Second Quarter 2020 Results

    6:00 a.m. July 23, 2020

    - PR Newswire - PRF

  2. Danaher Schedules Second Quarter 2020 Earnings Conference Call

    4:15 p.m. July 13, 2020

    - PR Newswire - PRF

  3. US Stocks Surging Above Pivot Point: $DHR $HON $RY

    3:41 p.m. June 29, 2020

    - The Market Signal

  4. Microplate System Market Competitive Research And Precise Outlook 2020 To 2026

    11:49 a.m. June 15, 2020

    - Market Insight Reports

  5. Large Cap Companies with Strong Market cap: $BHP $DHR $IBM

    9:48 a.m. June 11, 2020

    - The Market Signal

  6. Loading more headlines...
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.